Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Department of Nurse Anesthesia, Virginia Commonwealth University, Richmond, VG, USA.
BMC Health Serv Res. 2023 Jul 24;23(1):789. doi: 10.1186/s12913-023-09591-5.
To understand developers' perception of patient (versions of) guidelines (PVGs), and identify challenges during the PVG development, with the aim to inform methodological guidance for future PVG development.
We used a descriptive qualitative design. Semi-structured interviews were conducted virtually from December 2021 to April 2022, with a purposive sampling of 12 PVG developers from nine teams in China. Conventional and directed content analysis was used for data analysis.
The interviews identified PVG developers' understanding of PVGs, their current practice experience, and the challenges of developing PVGs. Participants believed PVGs were a type of health education material for patients; therefore, it should be based on patient needs and be understandable and accessible. Participants suggested that PVGs could be translated/adapted from one or several clinical practice guidelines (CPG), or developed de novo (i.e., the creation of an entirely new PVG with its own set of research questions that are independent of existing CPGs). Participants perceived those existing methodological guidelines for PVG development might not provide clear instructions for PVGs developed from multiple CPGs and from de novo development. Challenges to PVG development include (1) a lack of standardized and native guidance on developing PVGs; (2) a lack of standardized guidance on patient engagement; (3) other challenges: no publicly known and trusted platform that could disseminate PVGs; concerns about the conflicting interests with health professionals.
Our study suggests clarifying the concept of PVG is the primary task to develop PVGs and carry out related research. There is a need to make PVG developers realize the roles of PVGs, especially in helping decision-making, to maximize the effect of PVG. It is necessary to develop native consensus-based guidance considering developers' perspectives regarding PVGs.
了解开发者对患者指南（PVG）的认知，并识别在 PVG 开发过程中面临的挑战，旨在为未来的 PVG 开发提供方法学指导。
我们采用描述性定性设计。于 2021 年 12 月至 2022 年 4 月，通过在中国的九个团队中进行有针对性的抽样，对 12 名 PVG 开发者进行了虚拟半结构式访谈。采用常规和定向内容分析进行数据分析。
访谈确定了 PVG 开发者对 PVG 的理解、他们当前的实践经验以及开发 PVG 的挑战。参与者认为 PVG 是一种面向患者的健康教育材料；因此，它应该基于患者的需求，具有易懂性和可及性。参与者建议，PVG 可以从一个或多个临床实践指南（CPG）翻译/改编，或者从头开始开发（即创建一个具有自己一套独立于现有 CPG 的研究问题的全新 PVG）。参与者认为，现有的 PVG 开发方法学指南可能没有为从多个 CPG 和从头开始开发的 PVG 提供明确的指导。PVG 开发面临的挑战包括：（1）缺乏标准化和本土的 PVG 开发指南；（2）缺乏关于患者参与的标准化指南；（3）其他挑战：没有一个公开的、值得信赖的平台可以传播 PVG；对与卫生专业人员利益冲突的担忧。
我们的研究表明，明确 PVG 的概念是开发 PVG 并开展相关研究的首要任务。有必要使 PVG 开发者认识到 PVG 的作用，特别是在帮助决策方面，以最大限度地发挥 PVG 的效果。有必要从开发者的角度出发，制定基于本土共识的指南。
